ASP2151 clinical trials
Also written ASP2151.
How each study uses ASP2151 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ASP2151
- 12
Studies by the year they started
13 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 0
Maruho Europe Limited (5) · Astellas Pharma Inc (4) · Maruho Co., Ltd. (3) · Astellas Pharma Europe Ltd. (1)
Often tested with
Tested in the same studies.
Montelukast (1) · Ritonavir (1) · Valacyclovir (1) · Acyclovir (1)
Studies
Open first, then newest update. How each study uses ASP2151 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- Phase III Study of ASP2151 in Herpes Simplex PatientsCompletedPhase 3Maruho Co., Ltd.NCT01959295Written as ASP2151How we know
- Open-label Study of ASP2151 in Herpes Simplex PatientsCompletedPhase 3Maruho Co., Ltd.NCT02209324Written as ASP2151How we know
- Drug-Drug Interaction Study: ASP2151 and CiclosporinCompletedPhase 1Maruho Europe LimitedNCT02280421Written as ASP2151 400mg + 100mg ciclosporinHow we know
- Drug-Drug Interaction Study: ASP2151 and MontelukastCompletedPhase 1Maruho Europe LimitedNCT02321748Written as ASP2151How we know
- Drug-Drug Interaction Study: ASP2151 and RitonavirCompletedPhase 1Maruho Europe LimitedNCT02223351Written as ASP2151How we know
- Drug-Drug Interaction Study: ASP2151 and BupropionCompletedPhase 1Maruho Europe LimitedNCT02369172Written as ASP2151How we know
- Drug-Drug Interaction Study: ASP2151 and MidazolamCompletedPhase 1Maruho Europe LimitedNCT02403635Written as ASP2151How we know
- Phase III Study of ASP2151 in Herpes Zoster PatientsCompletedPhase 3Maruho Co., Ltd.NCT01959841Written as ASP2151How we know
- Dose-finding Study of ASP2151 in Subjects With Herpes ZosterCompletedPhase 2Astellas Pharma IncNCT00487682Written as ASP2151How we know
- A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesCompletedPhase 2Astellas Pharma IncNCT00486200Written as ASP2151How we know
- Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly SubjectsCompletedPhase 1Astellas Pharma IncNCT02796118Written as ASP2151How we know
- Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of FoodCompletedPhase 1Astellas Pharma Europe Ltd.NCT02852876Written as ASP2151How we know
- Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy VolunteersTerminatedPhase 1Astellas Pharma IncNCT00870441Written as ASP2151How we know